Medication Reconciliation: Process Overview and Reference Tool

Activity Details
  • Credit Type: CPE-T
  • Credit Amount: 0.75
  • Cost: Free
  • Release: Jan 8, 2021
  • Expires: Jan 7, 2024
  • Estimated Time to Complete:
    45 Minutes
  • System Requirements:
  • Average User Rating:
    ( Ratings)

Faculty

Troy D.  Butler Troy D. Butler, PharmD
PGY1 Pharmacy Resident
Ephraim McDowell Regional Medical Center
Danville, Kentucky

Needs Statement

Pharmacy technician-driven medication reconciliation has been shown to improve medication discrepancy identification and resolution in health systems. However, institutional medication history training for pharmacy technicians can be inconsistent and scarcely available within health systems, creating a barrier for pharmacy technicians to advance their practice. Literature has shown that pharmacy-technician obtained medication histories lead to better high-risk discrepancy identification and fewer medication reconciliation-related errors. Currently, this process is not led by the pharmacy team at every institution. It is our goal to provide a medication reconciliation tool and CE presentation to help pharmacy technicians advance their roles as medication reconciliation techs.

Target Audience

Pharmacy Technicians

Objectives

Upon completion of this activity participants will be able to:
1. Discuss the need and goals for advanced pharmacy technician medication reconciliation roles;
2. Review the medication reconciliation process and how to conduct a patient interview;
3. Explore the concept of using a medication reconciliation card deck tool to help prepare novice pharmacy technicians to find problem prone discrepancies in a medication history that might lead to medication errors or patient harm.

Accreditation

Joint Accreditation Logo

In support of improving patient care, this activity has been planned and implemented by University of Kentucky HealthCare CECentral and Epraim McDowell Regional Medical Center. University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

ACPE credit

This knowledge-based activity will award 0.75 contact hour (0.075 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers. 

Faculty Disclosure

No speakers, authors, planners or content reviewers have any relevant financial relationships to disclose.

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Acknowledgment

This activity is in collaboration with the Ephraim McDowell Regional Medical Center.

The activity was supported by Kentucky Society of Health System Pharmacists.

CE Content Concerns

Policy

Concerns or complaints related to ACPE or ACCME standards may be submitted in writing to the Director of UK HealthCare CECentral by fax to 859-323-2920, or by mail to 2365 Harrodsburg Road, Ste B475, Lexington, KY 40504

Procedures

  • The Director or his/her designee will review, investigate, forward and/or respond to complaints and will put forth a best effort to adjudicate the issue(s), along with CECentral staff members, within two (2) weeks of receipt of the grievance or complaint.
  • If needed, concerns, complaints, or grievances will be brought before the UK HealthCare CECentral Advisory Board.
  • Issues regarding activity content also will be reviewed and addressed by the Activity Director.
  • A written decision will be issued in a timely manner by the Director of UK HealthCare CECentral or his/herdesignee.
  • Grievances will be considered when planning future activities.

Appeal Procedure

  • Persons who wish to appeal a decision should address the appeal by email, fax or in writing to the Director of UK HealthCare CECentral within two (2) weeks of receipt of the response.
  • The Director will bring the appeal to the UK HealthCare CECentral Advisory Board.
  • The results of the appeal will be sent to the participant no later than two (2) weeks following the meeting of the board.